Filing Flows › Insmed (INSM) › ARIKAYCE revenue
Insmed (INSM) ARIKAYCE revenue by quarter
Insmed's ARIKAYCE revenue was $124M in Q3 2026 (third quarter 2026), +7% from Q2 2026. Over the last 5 quarters it ranged from $98.1M (Q1 2026) to $124M (Q3 2026).
| Quarter | ARIKAYCE revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $124M | +7% | +9% |
| Q2 2026 | $116M | +19% | — |
| Q1 2026 | $98.1M | -18% | — |
| Q4 2025 | $119M | +4% | — |
| Q3 2025 | $114M | — | — |
Q3 2026 at a glance
Insmed, Q3 2026: revenue $524M (+268% year over year), operating margin -17.0%, net loss $100M, operating cash flow −$36.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Insmed's ARIKAYCE revenue?
Insmed's ARIKAYCE revenue was $124M in Q3 2026 (third quarter 2026), +7% from Q2 2026.
How has Insmed's ARIKAYCE revenue changed?
Over the last 5 quarters it ranged from $98.1M (Q1 2026) to $124M (Q3 2026).